Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India · Delayed Price · Currency is INR 11,709
+36 (0.30%)
At close: Feb 13, 2026
BOM:500459 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 43,394 | 43,019 | 42,057 | 39,179 | 39,009 | 35,741 |
Other Revenue | 13.7 | 43.2 | - | - | - | - |
| 43,407 | 43,062 | 42,057 | 39,179 | 39,009 | 35,741 | |
Revenue Growth (YoY) | 0.56% | 2.39% | 7.35% | 0.43% | 9.14% | 19.06% |
Cost of Revenue | 16,083 | 16,407 | 16,292 | 16,710 | 15,675 | 11,651 |
Gross Profit | 27,324 | 26,655 | 25,765 | 22,469 | 23,335 | 24,091 |
Selling, General & Admin | 7,046 | 8,346 | 7,750 | 6,233 | 6,785 | 7,130 |
Other Operating Expenses | 8,534 | 8,165 | 7,893 | 7,469 | 8,129 | 7,944 |
Operating Expenses | 15,963 | 16,964 | 16,208 | 14,286 | 15,443 | 15,551 |
Operating Income | 11,361 | 9,691 | 9,557 | 8,183 | 7,892 | 8,540 |
Interest Expense | -67 | -88.6 | -202.5 | -52.6 | -59.4 | -13.7 |
Interest & Investment Income | 288.6 | 288.6 | 452.2 | 362.1 | 242.9 | 322.9 |
Currency Exchange Gain (Loss) | -39.1 | -39.1 | -37.3 | -43.7 | -70.1 | -10.9 |
Other Non Operating Income (Expenses) | 135.4 | 90.6 | 70.3 | 43.7 | 0.3 | 70.9 |
EBT Excluding Unusual Items | 11,679 | 9,942 | 9,839 | 8,493 | 8,006 | 8,909 |
Merger & Restructuring Charges | -32.6 | -32.6 | -135.6 | - | - | -8.6 |
Gain (Loss) on Sale of Assets | -2.3 | -2.3 | -55.4 | -8.3 | -17.6 | -18.5 |
Asset Writedown | 67.3 | -63 | -130.3 | - | - | -76.4 |
Other Unusual Items | -99.7 | -99.7 | -126.1 | -89.6 | -86.6 | -106.9 |
Pretax Income | 11,612 | 9,744 | 9,392 | 8,395 | 7,901 | 8,699 |
Income Tax Expense | 3,017 | 2,568 | 2,642 | 1,613 | 2,144 | 2,181 |
Net Income | 8,595 | 7,177 | 6,750 | 6,781 | 5,758 | 6,518 |
Net Income to Common | 8,595 | 7,177 | 6,750 | 6,781 | 5,758 | 6,518 |
Net Income Growth | 20.05% | 6.31% | -0.46% | 17.78% | -11.67% | 50.50% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change (YoY) | 0.00% | 0.00% | - | - | - | - |
EPS (Basic) | 264.77 | 221.08 | 207.95 | 208.91 | 177.37 | 200.79 |
EPS (Diluted) | 264.77 | 221.08 | 207.95 | 208.91 | 177.37 | 200.79 |
EPS Growth | 20.05% | 6.31% | -0.46% | 17.78% | -11.67% | 50.50% |
Free Cash Flow | - | 7,176 | 4,253 | 7,813 | 5,233 | 8,315 |
Free Cash Flow Per Share | - | 221.06 | 131.03 | 240.70 | 161.21 | 256.16 |
Dividend Per Share | - | 233.333 | 195.000 | 185.000 | 160.000 | 165.000 |
Dividend Growth | - | 19.66% | 5.41% | 15.63% | -3.03% | 57.14% |
Gross Margin | 62.95% | 61.90% | 61.26% | 57.35% | 59.82% | 67.40% |
Operating Margin | 26.17% | 22.50% | 22.72% | 20.89% | 20.23% | 23.89% |
Profit Margin | 19.80% | 16.67% | 16.05% | 17.31% | 14.76% | 18.24% |
Free Cash Flow Margin | - | 16.66% | 10.11% | 19.94% | 13.41% | 23.27% |
EBITDA | 11,738 | 10,106 | 10,111 | 8,756 | 8,407 | 9,002 |
EBITDA Margin | 27.04% | 23.47% | 24.04% | 22.35% | 21.55% | 25.19% |
D&A For EBITDA | 376.47 | 415.07 | 553.8 | 572.4 | 514.9 | 461.8 |
EBIT | 11,361 | 9,691 | 9,557 | 8,183 | 7,892 | 8,540 |
EBIT Margin | 26.17% | 22.50% | 22.72% | 20.89% | 20.23% | 23.89% |
Effective Tax Rate | 25.98% | 26.35% | 28.13% | 19.22% | 27.13% | 25.07% |
Revenue as Reported | 43,899 | 43,508 | 42,580 | 39,585 | 39,252 | 36,135 |
Advertising Expenses | - | - | 5,310 | 4,084 | 4,546 | 5,030 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.